# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-019368
Filing Date
2024-04-11
Accepted
2024-04-11 16:31:45
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20016134x2_defa14a.htm | DEFA14A | 7896
2 |  | ny20016134x2_nc01.jpg | GRAPHIC | 481614
3 |  | ny20016134x2_nc02.jpg | GRAPHIC | 392872
| Complete submission text file | 0001140361-24-019368.txt |  | 1213742

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 24838890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)